OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Registered number: 02211941 Charity number: 700272

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2021

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

CONTENTS

Page
Reference and administrative details of the Charitable Company, its Trustees and 1
advisers
Trustees' report 2 - 9
Independent auditors' report on the financial statements 10 - 14
Statement of financial activities 15
Balance sheet 16 - 17
Statement of cash flows 18
Notes to the financial statements 19 - 38

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITABLE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2021

Trustees J Alderson (appointed 18 November 2020)
J Baldwin
L Chapman
B Cooper
M Duncan
J Edge (resigned 31 July 2020)
R Laight
M Leech
D Locke
M Mushen
C Robertson (appointed 24 November 2020)
M Webb
Company registered
number
02211941
Charity registered
number
700272
Registered office
Primrose Hospice
St. Godwalds Road
Bromsgrove
Worcestershire
B60 3BW
Company secretary
A Dalton
Chief executive officer
D Burrell
Independent auditors
Bishop Fleming LLP
Chartered Accountants
1-3 College Yard
Worcester
WR1 2LB
Bankers
Lloyds Bank plc
112 High Street
Bromsgrove
Worcestershire
B61 8ES
Solicitors
Thomas Guise Solicitors
5 Foregate Street
Worcester
WR1 1DB

Page 1

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 MARCH 2021

The Trustees present their annual report together with the audited financial statements of the Charitable Company for the year 1 April 2020 to 31 March 2021. The Annual report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Charitable Company qualifies as small under section 382 of the Companies Act 2006, the Strategic report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Introduction

Based in Bromsgrove, Primrose Hospice is an established and highly respected charity. It has served the population of North East Worcestershire for over 34 years.

In 2020/21 Primrose Hospice raised £1.986 million (£1.87 million in 2019/20) which includes an annual grant from the NHS and retail grants from the government given in response to the COVID-19 pandemic. Around £0.84 million of the monies raised was achieved thanks to the generous support of local people and businesses. The money raised is spent on supporting people with life-limiting illnesses and their families during difficult and challenging times. Following a successful year in 2019, COVID-19 has dominated the activity of Primrose Hospice since early 2020.

Due to a prudent and rapid management response, Primrose Hospice acted to protect the long term viability of the organisation and ensure that Primrose Hospice continued to support the community during the COVID-19 pandemic.

Prioritising the safety of patients, clients, volunteers and staff at all times, Primrose Hospice adapted its services in light of rapidly changing guidance and continued to support the community during the COVID-19 pandemic in new and innovative ways.

Primrose Hospice is grateful for the financial support that has helped to ensure that the Hospice is a viable ongoing concern. Support has included:

The prudent internal management of finances and the adaptation of the services offered to the community means that Primrose Hospice has enhanced its reputation.

Primrose Hospice has invested in services during the pandemic increasing family support and care resources to support both patients and families.

We are proud that we have played our part in supporting our community during an extremely challenging period and are determined to play our part going forward.

Page 2

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

Objectives and activities

a. Policies and objectives

Primrose Hospice aims to work to support adults over the age of 18 living at home with cancer and other life limiting illnesses and to offer a high quality, efficient and responsive service appropriate to the needs of an individual whatever the stage of their illness.

The objectives of Primrose Hospice are:

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

b. Strategies for achieving objectives

Whilst the Charity developed a clear 5-year strategy in 2018, this has been revisited in 2020 to ensure we respond to the challenges and opportunities that the COVID-19 pandemic has presented.

Primrose Hospice has undertaken a clinical services review in 2020 and invested in additional nursing, medical and support posts. In addition a temporary increase in resources for family support have been allocated to help address an increase in demand for services and the complexity of supporting people safely during COVID.

Page 3

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

Objectives and activities (CONTINUED)

c. Activities undertaken to achieve objectives

Some of our services have been maintained remotely or utilising on line methods. Our staff have continued to support people face to face and in their homes on an exception basis after a full risk assessment.

Our core services include:

Care

Day Hospice

Outpatient clinics

Physiotherapy and Occupational Therapy

Wellbeing

Family Support

Adult groups currently on offer from Primrose Family Support

Bereavement Group

Week2Week Group

STEPs

SWAN

Page 4

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

Objectives and activities (CONTINUED)

Support Groups for Patients and their families

Men’s Group

Relaxation Group

Children’s Groups

Team Trevor

Water bugs and Dragonflies

Achievements and performance

a. Key performance indicators

Primrose Hospice’s priority has continued to provide care for those with life limiting illness. Primrose Hospice has adapted services during COVID to provide safe remote support where possible, supplemented by face to face and occasional group work following a full COVID risk assessment.

Primrose Hospice’s challenge continues to be to raise the funds to respond to the increase in need.

Primrose Hospice wanted to increase the levels of cash reserves so the Hospice could ensure that vital services would be maintained throughout any difficult period. Reserves were successfully increased from 10.5 months of operating costs in April 2020 to 12.8 months of operating costs in March 2021.

b. Review of activities

Primrose Hospice provides support to patients with life limiting illnesses and their families, providing them with the care and support they require during difficult times.

Page 5

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

Achievements and performance (CONTINUED)

c. Investment policy and performance

There are no restrictions on the powers of the Trustees to invest the funds of Primrose Hospice. The current policy of the Trustees is to have regard to income requirements and any risks which have been identified and to retain any such funds as are required in short term bank deposit accounts. Primrose Hospice seeks to produce the best financial return within an acceptable level of risk. The investment objective for the short term cash reserves is to preserve the capital value with a minimum level of risk. Assets should be readily available, within 35 days, to meet unanticipated cash flow requirements.

The Trustees have reviewed the reserves of the charity, including the nature of the income and expenditure streams, the need to match variable income and fixed commitments and the nature of the reserves.

An investment policy was reviewed and updated at the Finance and Income Generation Committee and Board in 2020.

Financial review

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charitable Company has adequate resources to continue in operational existence for the foreseeable future. This has been reviewed and the Trustees are confident there are sufficient reserves to ensure the Hospice remains a going concern beyond March 2023. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies (Note 2.2).

b. Reserves policy

The Trustees actively review the major risks which the Charity faces and believe that maintaining reserves at a level to cover 6 months operating costs, combined with an annual review of the controls over key financial systems, will provide sufficient resources in the event of adverse conditions. The organisation aspires to have 6 months’ reserves at any time (currently 12.8 months). The Trustees have also examined other operational and business risks faced by the Charity, have produced a Risk Register and confirm that they have established systems to mitigate the significant risks.

Whilst reserves are greater than the Charity aspires to in ‘normal’ times, the Trustees are aware that this has been achieved during the pandemic and is largely due to additional temporary financial support and temporarily decreased cost base (e.g. furlough). As there are risks around future income levels, Trustees have accepted maintaining additional reserves as a prudent buffer in a time of great uncertainty around future income for the Charity.

c. Financial review

The Statement of Financial Activities (SOFA) shows restricted and unrestricted reserves at £1,482,680 and £2,036,932, respectively. In 2019/20 they were £1,534,828 and £1,503,111 respectively.

Total incoming resources amounted to £1,986,498 (2020: £1,868,059), £812,813 of this was from statutory sources (£268,260 in 2020). For the other 40.9% (85.6% in 2020), Primrose Hospice remains heavily dependent on the generosity of our local community to support our retail shops, joint lottery and fundraising activities.

There was a surplus of £481,673 in 2021 (in 2020 the figure was £265,197).

Page 6

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

d. Principal funding

National Health Service Grants

Grant income from the NHS was £400,729, 20.2% of the Hospice’s total funding. Primrose Hospice ensures that the limited resources are used responsibly to provide the best care and support to our community.

Worcestershire Hospices Lottery

Worcestershire Hospices Lottery, a joint venture with Acorns Children’s Hospice and St. Richard’s Hospice, generated income of £117,391 (2020: £108,249) for the Hospice.

Donations (Charitable Trusts, Fundraising & other donations)

Donations in 2021 were £473,913 compared to £586,199 in 2020 which is a decrease of 19.1%.

Legacies and In Memoriam

Legacies and In Memoriam were £336,889 compared to £274,965 in 2020 which is an increase of 22.5%.

Trading Activities

The income generated by Primrose’s 5 retail shops was £215,733 compared to £605,350 in the previous year (which included the receipt of £105,000 in retail grants awarded by the government in response to the COVID 19 pandemic).

Structure, governance and management

a. Constitution

The Primrose Hospice is registered as a charitable company limited by guarantee and was set up by a Trust deed.

The Primrose Hospice is constituted under a Trust deed and is a registered charity number 700272.

The Primrose Hospice is a charitable company limited by guarantee, incorporated on 20th January 1988, and registered as a charity on the same date.

The Primrose Hospice was established under a Memorandum of Association, which established the objects and powers of the charitable company and is governed under its Articles of Association. In the event of the company being wound up, members are required to contribute an amount of £1 per member.

b. Methods of appointment or election of Trustees

The directors of the company are also charity trustees for the purposes of charity law and, under the company's Articles, are known as members of the Board of Trustees. The Trustees when complete consist of at least seven and not more than twenty individuals over the age of 18, all of whom must support the Objects. Under the requirements of the Memorandum and Articles of Association, one third (or the number nearest one third) of the Trustees must retire each year, those longest in office retiring first and the choice between any of equal service being made by drawing lots. A retiring Trustee may be re appointed for a further period of 3 years at the discretion of the Trustees.

Page 7

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

Structure, governance and management (CONTINUED)

c. Organisational structure and decision-making policies

The Board of Trustees administers the Charity. The Board meets at least 4 times a year and is responsible for the strategic direction and policy of the Charity.

The Chief Executive Officer is appointed by the Trustees to manage the day to day operations of the Charity and attends the Board Meetings, alongside members of the Senior Leadership Team. To facilitate effective operations, the Chief Executive Officer has delegated authority for operational matters.

d. Policies adopted for the induction and training of Trustees

The Trustees have a formal induction process which covers all Primrose Hospice policies and procedures and covers the Trustee Code of Conduct, the Trustee declaration, Confidentiality agreement, Nolan 7 Principles, The Charity Commission’s publication ‘The Essential Trustee’ The Hospice UK 20 minute guide and Mandatory Training as undertaken by all volunteers.

e. Pay policy for key management personnel

Salaries are reviewed to ensure resources are used as efficiently as possible. This, along with benchmarking against similar local charities and assessing the complexity of the role, will provide a robust remuneration process.

f. Financial risk management

The Trustees have assessed the major risks to which the Charitable Company is exposed, in particular those related to the operations and finances of the Charitable Company, and are satisfied that systems and procedures are in place to mitigate exposure to the major risks.

Plans for future periods

The Trustees and Senior Management Team plan to continue to deliver services for the Charity's clients, whilst managing the impacts of COVID-19 and other economic uncertainties on the Charity.

Page 8

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2021

STATEMENT OF TRUSTEES' RESPONSIBILITIES

The Trustees (who are also the directors of the Charitable Company for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charitable Company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charitable Company's transactions and disclose with reasonable accuracy at any time the financial position of the Charitable Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charitable Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to auditors

Each of the persons who are Trustees at the time when this Trustees' report is approved has confirmed that:

Auditors

The auditors, Bishop Fleming LLP, have indicated their willingness to continue in office. The designated Trustees will propose a motion reappointing the auditors at a meeting of the Trustees.

Approved by order of the members of the board of Trustees and signed on their behalf by:

R Laight Trustee Date: 6th October 2021

Page 9

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE PRIMROSE HOSPICE LIMITED

OPINION

We have audited the financial statements of The Primrose Hospice Limited (the 'charitable company') for the year ended 31 March 2021 which comprise the Statement of financial activities, the Balance sheet, the Statement of cash flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

BASIS FOR OPINION

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

CONCLUSIONS RELATING TO GOING CONCERN

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

OTHER INFORMATION

The other information comprises the information included in the Annual report other than the financial statements and our Auditors' report thereon. The Trustees are responsible for the other information contained within the Annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Page 10

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE PRIMROSE HOSPICE LIMITED (CONTINUED)

OPINION ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006

In our opinion, based on the work undertaken in the course of the audit:

MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:

RESPONSIBILITIES OF TRUSTEES

As explained more fully in the Trustees' responsibilities statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 11

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE PRIMROSE HOSPICE LIMITED (CONTINUED)

AUDITORS' RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Identifying and assessing potential risks related to irregularities;

The procedures undertaken in order to identify and assess risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, are as follows:

We have considered the matters discussed among the audit engagement team, including internal tax specialists regarding how and where fraud might occur in the financial statements and potential indicators of fraud.

As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas:

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override.

We also obtained an understanding of the legal and regulatory frameworks that the Charitable Company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the Charities SORP (FRS 102) - Accounting and Reporting by Charities and the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

In addition, we have considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the Charitable Company's ability to operate or to avoid a material penalty. These include data protection regulations, health and safety regulations and employment legislation.

Page 12

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE PRIMROSE HOSPICE LIMITED (CONTINUED)

Audit response to risks identified

As a result of performing the above procedures, we have identified revenue recognition and accounting estimates as key audit matters related to the potential risk of fraud. Our procedures to respond to risks identified included the following:

We also communicated relevant laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from an error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion. There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' report.

USE OF OUR REPORT

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

Page 13

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF THE PRIMROSE HOSPICE LIMITED (CONTINUED)

Andrew Wood FCCA (Senior statutory auditor) for and on behalf of

Bishop Fleming LLP Chartered Accountants Statutory Auditors 1-3 College Yard Worcester WR1 2LB

Date: 7th October 2021

Page 14

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2021

Note
Income from:
Donations and legacies
3
Charitable activities
4
Other trading activities
5
Investments
6
Total income
Expenditure on:
Raising funds
7
Charitable activities
8
Total expenditure
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward
Unrestricted
funds
2021
£
835,893
406,909
333,124
618
1,576,544
499,557
543,166
1,042,723
533,821
1,503,111
533,821
2,036,932
Restricted
funds
2021
£
409,954
-
-
-
409,954
-
462,102
462,102
(52,148)
1,534,828
(52,148)
1,482,680
Total
funds
2021
£
1,245,847
406,909
333,124
618
1,986,498
499,557
1,005,268
1,504,825
481,673
3,037,939
481,673
3,519,612
Total
funds
2020
£
884,799
268,260
713,599
1,401
1,868,059
629,662
973,200
1,602,862
265,197
2,772,742
265,197
3,037,939

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 19 to 38 form part of these financial statements.

Page 15

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE) REGISTERED NUMBER:02211941

BALANCE SHEET AS AT 31 MARCH 2021

Note
Fixed assets
Tangible assets
13
Investments
14
Current assets
Debtors
15
Cash at bank and in hand
Creditors: amounts falling due within one
year
16
Net current assets
Total assets less current liabilities
Total net assets
Charity funds
Restricted funds
19
Unrestricted funds
19
Total funds
133,483
1,579,618
1,713,101
(191,417)
2021
£
1,997,828
100
1,997,928
1,521,684
3,519,612
3,519,612
1,482,680
2,036,932
3,519,612
247,753
868,586
1,116,339
(150,577)
2020
£
2,072,077
100
2,072,177
965,762
3,037,939
3,037,939
1,534,828
1,503,111
3,037,939

Page 16

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE) REGISTERED NUMBER:02211941

BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2021

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on _______6th October 2021 and signed on their behalf by:

R Laight J Baldwin Trustee Trustee

The notes on pages 19 to 38 form part of these financial statements.

Page 17

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2021

Cash flows from operating activities
Net cash used in operating activities
Cash flows from investing activities
Dividends, interests and rents from investments
Proceeds from the sale of tangible fixed assets
Net cash provided by investing activities
Cash flows from financing activities
Net cash provided by financing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
The notes on pages 19 to 38 form part of these financial statements
2021
£
700,330
10,702
-
10,702
-
711,032
868,586
1,579,618
2020
£
258,055
1,401
750
2,151
-
260,206
608,380
868,586

Page 18

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

1. GENERAL INFORMATION

The Primrose Hospice is a private Charitable Company limited by guarantee, incorporated in the UK and registered in England and Wales. The registered office is Primrose Hospice, St. Godwalds Road, Bromsgrove, Worcestershire, B60 3BW.

The principal activity of the Charitable Company is as disclosed in the Trustees' report, starting on page 2.

The accounts are presented in GBP and are rounded to the nearest GBP.

2. ACCOUNTING POLICIES

2.1 BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The Primrose Hospice Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 GOING CONCERN

The Trustees have prepared financial projection forecasts for a period of at least 18 months following the date of approval of the financial statements. The Charitable Company has a net asset value as at 31 March 2021 of £3,519,266 (2020: £3,037,939), and has freehold property with a net book value totalling £1,971,062 (2020: £2,026,258) and cash at bank and in hand of £1,579,618 (2020: £868,524).

On this basis the financial statements have been prepared on a going concern basis. The Trustees’ assumptions and outlook considers the impact and uncertainty that the Coronavirus (COVID-19) pandemic continues to have on the Charitable Company. Updated projections have been put in place that consider a worst-case scenario in order to make sure the Charitable Company continues during these unprecedented times. This is being monitored on a weekly basis. The Trustees have also taken advantage of the COVID-19 Government assistance throughout the financial year as well as funding from other funding bodies; a number of successful grants have been secured during the year.

The financial statements do not reflect the adjustments that would be necessary should the ability of the Charitable Company to operate be jeopardised due to a material issue with the availability of its work force, the level of demand for its services or a material decrease in shop revenues or grant funding.

Page 19

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

2. ACCOUNTING POLICIES (continued)

2.3 INCOME

All income is recognised once the Charitable Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Charitable Company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Charitable Company, can be reliably measured.

Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

2.4 EXPENDITURE

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on raising funds includes all expenditure incurred by the Charitable Company to raise funds for its charitable purposes and includes costs of all fundraising activities events and noncharitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charitable Company's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

2.5 GOVERNMENT GRANTS

Government grants relating to tangible fixed assets are treated as deferred income and released to the Statement of financial activities over the expected useful lives of the assets concerned. Other grants are credited to the Statement of financial activities as the related expenditure is incurred.

2.6 INTEREST RECEIVABLE

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charitable Company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

Page 20

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

2. ACCOUNTING POLICIES (continued)

2.7 TAXATION

The Charitable Company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Charitable Company is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

2.8 TANGIBLE FIXED ASSETS AND DEPRECIATION

Tangible fixed assets costing £5,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following bases:

Freehold property - 2-10% straight line
Motor vehicles - 25% reducing balance
Fixtures and fittings - 25% straight line
Office equipment - 25% straight line

2.9 INVESTMENTS

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of financial activities.

Investments in joint ventures are stated at the amount of the Charitable Company's share of net assets. The Statement of financial activities includes the Charitable Company's share of the joint ventures' net income or expenditure using the equity accounting basis. As the joint venture is a charity, the investment is presented within restricted funds.

2.10 STOCKS

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

2.11 DEBTORS

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Page 21

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

2. ACCOUNTING POLICIES (continued)

2.12 CASH AT BANK AND IN HAND

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.13 LIABILITIES AND PROVISIONS

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charitable Company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.

2.14 FINANCIAL INSTRUMENTS

The Charitable Company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2.15 PENSIONS

The Charitable Company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charitable Company to the fund in respect of the year.

2.16 FUND ACCOUNTING

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charitable Company and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charitable Company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 22

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

3. INCOME FROM DONATIONS AND LEGACIES

Unrestricted
funds
2021
£
Donations
470,863
Legacies
284,278
Children in Need grant
28,141
Government grants
-
In memoriam
52,611
835,893
TOTAL 2020
784,830
Restricted
funds
2021
£
3,050
-
-
406,904
-
409,954
99,969
Total
funds
2021
£
473,913
284,278
28,141
406,904
52,611
1,245,847
884,799
Total
funds
2020
£
586,199
191,645
23,635
-
83,320
884,799

4. INCOME FROM CHARITABLE ACTIVITIES

Unrestricted
funds
2021
£
CCG funding - Hospice services
400,729
Student placement income
6,180
406,909
TOTAL 2020
268,260
Total
funds
2021
£
400,729
6,180
406,909
268,260
Total
funds
2020
£
259,745
8,515
268,260

During 2020/2021 we were able to increase our level of reserves. This was due to temporary reductions in expenditure during COVID-19 pandemic and non-recurrent income from sources related to the pandemic: Job Retention Scheme (furlough), COVID-19 grants (e.g. retail), additional funding from the Clinical Commissioning Group (CCG) and treasury funding to Hospices. In addition, we benefited from significant income from legacies which again is non recurrent and largely unpredictable.

Whilst this temporary increase in income supported us to maintain and expand services whilst building reserves, it is clear that the future levels of income for an organisation that is largely self-funding from fundraising and retail is less predictable. Reserves have been allocated to additional services in Family Support and Care but we remain vigilant in our future planning until there is a clearer view on the recovery of our sustainable , recurrent income streams.

Page 23

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

5. INCOME FROM OTHER TRADING ACTIVITIES

Income from fundraising events

Unrestricted
funds
2021
£
Shop and eBay sales
141,883
Ragging income
4,932
Gift Aid income
6,526
Other income
-
Retail, Hospitality and Leisure grants
62,392
215,733
TOTAL 2020
605,350
Income from non charitable trading activities
Unrestricted
funds
2021
£
Lottery joint venture income
117,391
TOTAL 2020
108,249
6.
INVESTMENT INCOME
Unrestricted
funds
2021
£
Investment income
618
TOTAL 2020
1,401
Total
funds
2021
£
141,883
4,932
6,526
-
62,392
215,733
605,350
Total
funds
2021
£
117,391
108,249
Total
funds
2021
£
618
1,401
Total
funds
2020
£
451,162
17,222
31,710
256
105,000
605,350
Total
funds
2020
£
108,249
Total
funds
2020
£
1,401

Page 24

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

7. EXPENDITURE ON RAISING FUNDS

FUNDRAISING EXPENSES

Unrestricted
funds
2021
£
Fundraising non-staff costs
27,563
Fundraising staff costs
141,785
169,348
TOTAL 2020
213,221
CHARITY SHOP EXPENSES
Unrestricted
funds
2021
£
Charity shop non-staff costs
136,340
Charity staff costs
193,869
Charity shop depreciation
-
330,209
TOTAL 2020
416,441
Total
funds
2021
£
27,563
141,785
169,348
213,221
Total
funds
2021
£
136,340
193,869
-
330,209
416,441
Total
funds
2020
£
72,885
140,336
213,221
Total
funds
2020
£
203,041
205,585
7,815
416,441

Page 25

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

8. ANALYSIS OF EXPENDITURE ON CHARITABLE ACTIVITIES

Summary by fund type

Unrestricted
funds
2021
£
Operation of Hospice
543,166
TOTAL 2020
818,897
Restricted
funds
2021
£
462,102
154,303
Total
funds
2021
£
1,005,268
973,200
Total
funds
2020
£
973,200

9. ANALYSIS OF EXPENDITURE BY ACTIVITIES

Operation of Hospice
TOTAL 2020
Activities
undertaken
directly
2021
£
696,149
697,801
Support
costs
2021
£
309,119
275,399
Total
funds
2021
£
1,005,268
973,200
Total
funds
2020
£
973,200

Page 26

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

9. ANALYSIS OF EXPENDITURE BY ACTIVITIES (CONTINUED)

ANALYSIS OF DIRECT COSTS

Staff costs
Depreciation
Project costs
Care equipment
Utilities
Education and training
Laundry and cleaning
Patient interaction
Repairs and maintenance
Printing, stationery and postage
Consumables
Travel
TOTAL 2020
Activities
2021
£
471,012
74,249
3,639
712
32,988
4,400
22,351
51,896
25,114
4,083
161
5,544
696,149
697,801
Total
funds
2021
£
471,012
74,249
3,639
712
32,988
4,400
22,351
51,896
25,114
4,083
161
5,544
696,149
697,801
Total
funds
2020
£
466,155
64,234
3,163
312
18,339
6,327
27,911
56,774
21,196
5,510
8,101
19,779
697,801

Page 27

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

9. ANALYSIS OF EXPENDITURE BY ACTIVITIES (CONTINUED)

ANALYSIS OF SUPPORT COSTS

Activities
2021
£
Staff costs
216,585
Recruitment expenses
1,082
Insurance
13,799
IT consumables
25,481
Education and training
214
Telephone
7,823
Miscellaneous expenses
6,348
Consultancy fees
22,954
Audit and accountancy fees
11,520
Printing, stationery and postage
3,137
Bank charges
176
309,119
TOTAL 2020
275,399
10.
AUDITORS' REMUNERATION
Fees payable to the Charitable Company's auditor for the audit of the
Charitable Company's annual accounts
Fees payable to the Charitable Company's auditor in respect of:
Preparation of the annual accounts
11.
STAFF COSTS
Wages and salaries
Social security costs
Contribution to defined contribution pension schemes
Total
funds
2021
£
216,585
1,082
13,799
25,481
214
7,823
6,348
22,954
11,520
3,137
176
309,119
275,399
2021
£
8,000
2,150
2021
£
906,880
67,920
48,451
1,023,251
Total
funds
2020
£
217,661
1,703
10,015
15,150
2,465
717
7,102
6,328
10,825
3,286
147
275,399
2020
£
7,775
2,100
2020
£
911,682
67,598
50,457
1,029,737

Page 28

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

11. STAFF COSTS (CONTINUED)

The average number of persons employed by the Charitable Company during the year was as follows:

Hospice services
Fundraising
Management & administration
Merchandising
2021
No.
24
6
7
12
49
2020
No.
27
6
7
12
52

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2021 2020
No. No.
In the band £60,001 - £70,000 1 1

The key management personnel of the Charitable Company is represented by the roles of Chief Executive Officer, Head of Clinical Services, Head of Family Support and Chief Operating Officer. The total employee benefits of the key management personnel were £198,670 (2020: £252,751), including employer's pension and National Insurance contributions.

12. TRUSTEES' REMUNERATION AND EXPENSES

During the year, no Trustees received any remuneration or other benefits (2020 - £NIL).

During the year ended 31 March 2021, no Trustee expenses have been incurred (2020 - £NIL).

Page 29

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

13. TANGIBLE FIXED ASSETS

COST OR VALUATION
At 1 April 2020
At 31 March 2021
DEPRECIATION
At 1 April 2020
Charge for the year
At 31 March 2021
NET BOOK VALUE
At 31 March 2021
At 31 March 2020
Freehold
property
£
2,684,955
2,684,955
658,697
55,196
713,893
1,971,062
2,026,258
Motor
vehicles
£
15,730
15,730
7,802
1,981
9,783
5,947
7,928
Fixtures and
fittings
£
74,956
74,956
55,581
8,804
64,385
10,571
19,375
Office
equipment
£
36,506
36,506
17,990
8,268
26,258
10,248
18,516
Total
£
2,812,147
2,812,147
740,070
74,249
814,319
1,997,828
2,072,077

14. FIXED ASSET INVESTMENTS

COST OR VALUATION
At 1 April 2020
AT 31 MARCH 2021
NET BOOK VALUE
AT 31 MARCH 2021
AT 31 MARCH 2020
Investment
in joint
ventures
£
100
100
100
100

Page 30

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

14. FIXED ASSET INVESTMENTS (CONTINUED)

PRINCIPAL JOINT VENTURES

The following was a joint venture of the Charitable Company:

Name Fair value of Profit for
investment the year
£ £
Worcestershire Hospices Lottery Limited 100 116,499

The Charitable Company has a one third shared holding in a joint venture, Worcester Hospices Lottery Limited, which entitles the Charitable Company to a third of its distributable reserves.

15. DEBTORS

DUE WITHIN ONE YEAR
Trade debtors
Amounts owed by joint venture
Other debtors
Prepayments and accrued income
Tax recoverable
2021
£
475
7,782
2,179
107,931
15,116
133,483
2020
£
2,070
8,359
-
229,323
8,001
247,753

16. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Trade creditors
Other creditors
Accruals and deferred income
2021
£
104,058
13,023
74,336
191,417
2020
£
85,955
11,270
53,352
150,577

Page 31

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

17. FINANCIAL INSTRUMENTS

2021 2020
£ £
FINANCIAL ASSETS
Financial assets measured at fair value through income and expenditure 1,579,618 868,586

Financial assets measured at fair value through income and expenditure comprise cash at bank and in hand.

18. ACCRUALS AND DEFERRED INCOME

Deferred income at 1 April 2020
Resources deferred during the year
Amounts released from previous periods
DEFERRED INCOME AT 31 MARCH 2021
2021
£
4,428
-
(4,428)
-
2020
£
9,278
4,428
(9,278)
4,428

Page 32

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

19. STATEMENT OF FUNDS

STATEMENT OF FUNDS - CURRENT YEAR

UNRESTRICTED FUNDS
General funds
RESTRICTED FUNDS
2004 Capital Appeal
2008 Squaring the Circle
Bromsgrove District Council
Department of Health - 2010 grant
Grand Lodge of Mark Master Masons
Sensory Garden
Department of Health - Garden Room
Interserve
Bumblehole Foods
JRS Scheme
NHSE Funding
Other small funds
TOTAL OF FUNDS
Balance at 1
April 2020
£
1,503,111
326,353
107,330
7,697
587,120
33,718
9,000
445,332
1,506
8,821
-
-
7,951
1,534,828
3,037,939
Income
£
1,576,544
-
-
-
-
-
-
-
-
-
150,881
256,023
3,050
409,954
1,986,498
Expenditure
£
(1,042,723)
(9,742)
(2,825)
(1,982)
(14,320)
(823)
(2,000)
(10,064)
(448)
(3,529)
(150,881)
(256,023)
(9,465)
(462,102)
(1,504,825)
Balance at
31 March
2021
£
2,036,932
316,611
104,505
5,715
572,800
32,895
7,000
435,268
1,058
5,292
-
-
1,536
1,482,680
3,519,612

Page 33

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

19. STATEMENT OF FUNDS (CONTINUED)

The specific purposes for which the funds are to be applied are as follows:

Restricted:

2004 Capital Appeal - Funding raised by the charity for an extension to the original building and are reduced annually by an amount equivalent to the depreciation charge in respect of that building cost.

2008 Squaring the Circle - Funding received from the Department of Health supporting Dignity in Care for older people. The grant funded the construction of a covered walkway and a hexagonal spiritual room, the cost of which is depreciated annually.

Bromsgrove District Council - The funds were received to fund our new Wellbeing project, designed to support people with a life limiting illness in managing and maintaining their quality of life.

Department of Health - Garden Room - Funding received from the Department of Health to provide new accommodation space for day patients.

Grand Lodge of Mark Master Masons - Funds raised by the charity for the fixtures, fittings and equipment in the family support centre.

Morrisons Foundation - Funds were received for the provision of our Children’s and Young Persons Service, supporting children through pre and post bereavement.

Bumblehole Foods - Funds received to install new LED lights into the main Hospice building and the Coppice Centre, thus reducing ongoing costs and environmental impact.

JRS Scheme - Funds received for the purposes of furloughing certain members of staff throughout the COVID-19 crisis.

NHSE Funding - The funds were received by Hospice UK for the purposes of support at various points throughout the COVID-19 crisis.

Other small funds - A number of additional donations were received throughout the year, supporting the purchase of essential items and services, such as chairs, carpets, complementary therapy supplies, medical consumables and new carpeting for our Hospice reception area.

Page 34

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

19.
STATEMENT OF FUNDS (CONTINUED)
STATEMENT OF FUNDS - PRIOR YEAR
UNRESTRICTED FUNDS
General funds
RESTRICTED FUNDS
2004 Capital Appeal
2008 Squaring the Circle
Bromsgrove District Council
Bromsgrove District Council (van)
Department of Health - 2010 grant
Grand Lodge of Mark Master Masons
Sensory Garden
The Rowlands Trust
Department of Health - Garden Room
Interserve
Morrisons Foundation
Bumblehole Foods
Edward Cadbury Charitable Trust
Edward Gosling Foundation
Crem Metals
Garfield Weston
JRS Scheme
NHSE Funding
Other small funds
TOTAL OF FUNDS
Balance at
1 April 2019
£
1,183,580
336,095
110,155
10,996
7,620
601,440
34,541
11,000
4,559
455,396
1,954
1,141
1,577
5,000
-
-
-
-
-
7,688
1,589,162
2,772,742
Income
£
1,768,090
-
-
7,958
-
-
-
-
4,114
-
-
17,654
-
5,000
1,659
8,000
15,000
9,468
4,265
26,851
99,969
99,969
Expenditure
£
(1,448,559)
(9,742)
(2,825)
(11,257)
(7,620)
(14,320)
(823)
(2,000)
(8,673)
(10,064)
(448)
(18,795)
7,244
(10,000)
(1,659)
(8,000)
(15,000)
(9,468)
(4,265)
(26,588)
(154,303)
(1,602,862)
Balance at
31 March
2020
£
1,503,111
326,353
107,330
7,697
-
587,120
33,718
9,000
-
445,332
1,506
-
8,821
-
-
-
-
-
-
7,951
1,534,828
3,037,939

Page 35

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

20. SUMMARY OF FUNDS

SUMMARY OF FUNDS - CURRENT YEAR

General funds
Restricted funds
SUMMARY OF FUNDS - PRIOR YEAR
General funds
Restricted funds
Balance at 1
April 2020
£
1,503,111
1,534,828
3,037,939
Balance at
1 April 2019
£
1,183,580
1,589,162
2,772,742
Income
£
1,576,544
409,954
1,986,498
Income
£
1,768,090
99,969
1,868,059
Expenditure
£
(1,042,723)
(462,102)
(1,504,825)
Expenditure
£
(1,448,559)
(154,303)
(1,602,862)
Balance at
31 March
2021
£
2,036,932
1,482,680
3,519,612
Balance at
31 March
2020
£
1,503,111
1,534,828
3,037,939

21. ANALYSIS OF NET ASSETS BETWEEN FUNDS

ANALYSIS OF NET ASSETS BETWEEN FUNDS - CURRENT YEAR

Unrestricted
funds
2021
£
Tangible fixed assets
527,691
Fixed asset investments
100
Current assets
1,700,558
Creditors due within one year
(191,417)
TOTAL
2,036,932
Restricted
funds
2021
£
1,470,137
-
12,543
-
1,482,680
Total
funds
2021
£
1,997,828
100
1,713,101
(191,417)
3,519,612

Page 36

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

21. ANALYSIS OF NET ASSETS BETWEEN FUNDS (CONTINUED) ANALYSIS OF NET ASSETS BETWEEN FUNDS - PRIOR YEAR

Unrestricted
funds
2020
£
Tangible fixed assets
556,052
Fixed asset investments
100
Current assets
1,097,536
Creditors due within one year
(150,577)
TOTAL
1,503,111
22.
RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW
ACTIVITIES
Net income for the year (as per Statement of Financial Activities)
ADJUSTMENTS FOR:
Depreciation charges
Dividends, interests and rents from investments
(Increase)/decrease in debtors
Increase in creditors
Profit on disposal of fixed assets
NET CASH PROVIDED BY OPERATING ACTIVITIES
23.
ANALYSIS OF CASH AND CASH EQUIVALENTS
Cash in hand
TOTAL CASH AND CASH EQUIVALENTS
Restricted
funds
2020
Total
funds
2020
£
£
1,516,025
2,072,077
-
100
18,803
1,116,339
-
(150,577)
1,534,828
3,037,939
FROM OPERATING
2021
2020
£
£
481,673
265,197
74,249
74,246
(10,702)
(1,401)
114,270
(83,583)
40,840
4,157
-
(561)
700,330
258,055
2021
2020
£
£
1,579,618
868,586
1,579,618
868,586

Page 37

THE PRIMROSE HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021

24. ANALYSIS OF CHANGES IN NET DEBT

At 1 April At 31 March
2020 Cash flows 2021
£ £ £
Cash at bank and in hand 868,586 711,032 1,579,618

25. PENSION COMMITMENTS

The Charitable Company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the group in an independently administered fund. The pension cost charge represents contributions payable by the Charitable Company to the fund and amounted to £50,630 (2020: £50,457). Contributions totalling £6,340 (2020: £5,135) were payable to the fund at the balance sheet date.

26. OPERATING LEASE COMMITMENTS

At 31 March 2021 the Charitable Company had commitments to make future minimum lease payments under non-cancellable operating leases as follows:

Not later than 1 year
Later than 1 year and not later than 5 years
Later than 5 years
2021
£
67,284
132,738
54,083
254,105
2020
£
85,034
170,344
54,083
309,461

27. RELATED PARTY TRANSACTIONS

During the year the Charity generated income of £116,499 (2020: £108,249) via a joint venture enterprise, Worcestershire Hospices Lottery Limited, which has a Trustee in common, M Leech. The amount due to the Charity at the year end amounted to £7,782 (2020: £8,421). During the year, expenditure of £NIL (2020: £268) was also incurred with this entity. At the year end, a balance of £62 was owed to this entity (2020: £NIL).

Page 38